David Ashton - Concepedia

Author

David Ashton

Janssen (Belgium)

Also Known As

D Ashton, D. Ashton, DAVID S. ASHTON, David ASHTON, David Ashton, David S Ashton, David S. Ashton

Publications

2.6K

Citations

H-Index

Concepts

All Affiliations

Janssen (Belgium)Wellcome Trust University of London Janssen (France)

About

David Ashton is an author at Janssen (Belgium) specializing in medicine, neuropharmacology, and neuroscience.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	23	2.1K
2	Social Sciences	11	11	418
3	Natural Sciences	4	4	111
4	Engineering	3	3	80
5	Health Sciences	2	2	36

David Ashton

Publications

2.5K

Citations

H-Index

Page 1

	Year	Citations
L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation Richard Palmer, Daryl D. Rees, David Ashton, Biochemical and Biophysical Research Communications Molecular PhysiologyBiochemistryPhysiological PrecursorNitric OxideReactive Nitrogen Specie	1988	1.3K
The characterization of micro-organisms by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry Kevin J. Welham, Marek Domin, D. Eoin Scannell, Rapid Communications in Mass Spectrometry	1998	136
Anxiolytic- and antidepressant-like profile of a new CRF1 receptor antagonist, R278995/CRA0450 Shigeyuki Chaki, Atsuro Nakazato, Ludo Kennis, European Journal of Pharmacology Molecular PharmacologyAntidepressant-like ProfilePsychiatryMedicinePsychotropic Medication	2003	123
Behavioral analysis of amygdaloid kindling in beagle dogs and the effects of clonazepam, diazepam, phenobarbital, diphenylhydantoin, and flunarizine on seizure manifestation A. Wauquier, David Ashton, W. Melis Experimental Neurology NeuropsychologyVeterinary Behavioral MedicineAmygdaloid KindlingNeurophysiologyBehavioral Neuroscience	1979	80
Dorsal-ventral gradient in vulnerability of CA1 hippocampus to ischemia: a combined histological and electrophysiological study David Ashton, Jos Van Reempts, Marc Haseldonckx, Brain Research Synaptic PlasticityNeurophysiologyCellular NeuroscienceNeuroanatomyPhysiology	1989	68
The effect of solvent and matrix combinations on the analysis of bacteria by matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry Marek Domin, Kevin J. Welham, David Ashton Rapid Communications in Mass Spectrometry	1999	59
Altered Na+-channel function as an in vitro model of the ischemic penumbra: action of lubeluzole and other neuroprotective drugs David Ashton, Roland Willems, Jozef Wynants, Brain Research NeurophysiologyMedicineSynaptic TransmissionPhysiologyAltered Na+-channel Function	1997	57
“Calcium Entry Blockers” as Cerebral Protecting Agents: Comparative Activity in Tests of Hypoxia and Hyperexcitability A. Wauquier, David Ashton, Gilbert Clincke, The Japanese Journal of Pharmacology	1985	51
Mass Spectrometry of the Humanized Monoclonal Antibody Campath 1H David Ashton, C.R. Beddell, David J. Cooper, Analytical Chemistry ImmunologyBiological Mass SpectrometryGlycobiologyPathologyBioanalysis	1995	47
Modulation of a GABA-Ergic Inhibitory Circuit in the In Vitro Hippocampus by Etomidate Isomers David Ashton, A. Wauquier Anesthesia & Analgesia	1985	46

Page 1